Evelo Biosciences Inc. (EVLO)
0.00
-0.00 (-100.00%)
At close: Feb 27, 2025, 3:00 PM
0.32
12536.00%
After-hours: Dec 11, 2023, 06:46 PM EST
Evelo Biosciences Balance Sheet Statement
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Cash & Equivalents | 47.94M | 68.44M | 68.86M | 77.83M | 147.92M | 38.25M | 15.54M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 54.82M | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 1.16M | 1.31M | 3.55M | 4.75M | 5.02M | 1.51M | 346K |
| Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 3.63M | 2.58M | 2.12M | 3.18M | 3.7M | 531K | 184K |
| Total Current Assets | 51.57M | 71.03M | 68.86M | 77.83M | 147.92M | 38.78M | 15.72M |
| Property-Plant & Equipment | 11.71M | 15.53M | 18.23M | 8.34M | 6.92M | 3.5M | 2.5M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 12.87M | 16.84M | 21.78M | 13.09M | 11.95M | 5.01M | 2.85M |
| Total Assets | 64.44M | 87.87M | 90.64M | 90.92M | 159.87M | 43.79M | 18.57M |
| Account Payables | 1.76M | 1.6M | 1.44M | 620K | 1.52M | 1.41M | 637K |
| Deferred Revenue | n/a | 13.07M | -2.14M | n/a | n/a | n/a | n/a |
| Short-Term Debt | 2.26M | 3.9M | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 8.37M | -7.04M | 18.39M | 9.12M | 7.72M | 2.43M | 1.61M |
| Total Current Liabilities | 12.39M | 17.36M | 19.83M | 9.74M | 9.23M | 3.84M | 2.25M |
| Long-Term Debt | 48.88M | 54.34M | 40.04M | 19.63M | 12.3M | 9.97M | 9.93M |
| Other Long-Term Liabilities | 8.16M | n/a | 284K | 1.35M | 1.38M | 580K | 865K |
| Total Long-Term Liabilities | 57.04M | 61.84M | 40.32M | 20.98M | 13.68M | 10.55M | 10.8M |
| Total Liabilities | 69.43M | 79.2M | 60.15M | 30.72M | 22.92M | 14.38M | 13.04M |
| Total Debt | 51.14M | 56.29M | 40.04M | 19.63M | 12.3M | 9.97M | 9.93M |
| Common Stock | 111K | 54K | 47K | 32K | 32K | 20K | 4K |
| Retained Earnings | -529.22M | -414.69M | -292.52M | -198.85M | -113.38M | -56.41M | -28.34M |
| Comprehensive Income | n/a | n/a | n/a | -90.92M | -18K | -1.43M | -595K |
| Shareholders Equity | -4.99M | 8.67M | 30.48M | 60.2M | 136.95M | 29.4M | 5.53M |
| Total Investments | n/a | n/a | n/a | n/a | 54.82M | n/a | n/a |